ROCO
3430
Market cap117mUSD
Oct 08, Last price
111.00TWD
1D
-1.77%
1Q
-13.28%
Jan 2017
662.36%
IPO
506.23%
Name
Chitec Technology Co Ltd
Chart & performance
P/E
35.19
P/S
2.19
EPS
3.15
Div yield, %
2.25%
Shrs. gr., 5y
2.35%
Rev. gr., 5y
8.09%
Revenues
1.71b
+16.19%
Net income
106m
-34.09%
CFO
135m
-5.58%
Dividend
Jul 09, 20261.6 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chitec Technology Co., Ltd. is a global enterprise dedicated to the research and development of specialized chemical solutions. These advanced materials serve a broad spectrum of applications across various industries, such as electronics, healthcare, automotive, and construction. Its extensive product range features several proprietary brands, including 'Chiguard' for UV absorbers and light stabilizers, 'Zuran' for flame retardants, 'Revonox/Deox' for antioxidants, and 'Chivacure/R-gen' for photoinitiators. Furthermore, the 'Chitex' brand covers anti-reversion agents, antiozoants, optical brighteners, and auxiliary thermal stabilizers. The company, founded in 1998, is headquartered in Taipei City, Taiwan.
Key people
Xiaofen Long
Chairman of the Board, General Manager · since 2023
Tingting Lin
Assistant General Manager-Finance and Accounting · since 2011
Zhuoji Zhong
Director · since 2020
Jingling Chen
Independent Director · since 2023
Zhiwei Chen
Independent Director · since 2023
Shaoyu Liu
Independent Director · since 2017
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||